Acasti Pharma reported CAD-3567000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acasti Pharma ACST:US C$ -3567000 1.27M
Addus Homecare ADUS:US $ 18.36M 1.61M
Agile Therapeutics AGRX:US $ -15774000 877K
Amarin AMRN:US 1.04M 7.73M
Bioscrip BIOS:US $ 52.88M 4.79M
Genetic Technologies GENE:US -3724990 180.14K
Pain Therapeutics PTIE:US $ -9753000 4.62M